Skip to Content Facebook Feature Image

IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026

Business

IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026
Business

Business

IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026

2026-03-28 05:02 Last Updated At:15:00

NEW YORK--(BUSINESS WIRE)--Mar 27, 2026--

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) and reminds investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260327317561/en/

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendant Patrick Soon-Shiong materially overstated Anktiva’s capabilities; and (2) as a result, defendants’ statements about ImmunityBio’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On January 23, 2026, ImmunityBio issued a press release "announc[ing] updated Phase 2 clinical results from QUILT 3.078 (NCT06061809), evaluating a chemotherapy-free combination immunotherapy regimen in patients with second-line recurrent or progressive glioblastoma (GBM), as well as patients treated under single-patient INDs (spINDs) across first- to third-line disease." Among other results, the press release disclosed that "median overall survival"-the primary endpoint for the trial-"has not yet been reached[.]"

On this news, ImmunityBio's stock price fell $0.89 per share, or 12.13%, to close at $6.45 per share on January 23, 2026.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding ImmunityBio’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the ImmunityBio class action, go to www.faruqilaw.com/IBRX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026

IBRX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026

BALTIMORE (AP) — Jackson Holliday hit his third career grand slam, Brandon Young pitched seven scoreless innings and the Baltimore Orioles beat the Seattle Mariners 7-2 on Wednesday night to snap a four-game losing streak.

Holliday became the first player in franchise history with three grand slams before turning 23. The 22-year-old infielder has 25 major league home runs.

Young (5-1) gave up two hits, walked two and struck out five. Baltimore is 9-1 in games started by Young this season.

Pete Alonso hit a solo homer and singled, and Leody Taveras went 2 for 3 with an RBI double.

Alonso's leadoff drive in the sixth opened the scoring. Colter Cowser walked four pitches later, stole second base and scored on a double by Taveras, who then stole third before Blaze Alexander hit a ground-rule double with two outs that made it 3-0.

Holliday's slam extended it to 7-0 in the seventh before Seattle got two runs in the eighth. Miles Mastrobuoni scored on a groundout by Julio Rodríguez, and Josh Naylor singled home Patrick Wisdom.

Seattle starter George Kirby (5-6) allowed three runs and seven hits in six innings. He walked three and finished with a season-high 10 strikeouts.

The Mariners are 4-17 this season when they do not hit a home run.

Seattle went into the game an MLB-best 11-3 (.786) since May 25.

The Orioles went 4 for 13 with runners in scoring position. Baltimore hit .129 (4 for 31) with runners in scoring position, including 1 for 11 on Tuesday in a 6-5 loss in 10 innings, during its four-game skid.

The matchup was the third of seven between the clubs in an 11-game stretch, with the Orioles traveling to Seattle for a three-game series next week.

Mariners RHP Bryan Woo (5-4, 3.74 ERA) starts Thursday opposite Kyle Bradish (3-7, 3.89) in the finale of the four-game series.

AP MLB: https://apnews.com/hub/MLB

Seattle Mariners pitcher George Kirby walks back onto the mound after surrendering a home run to Baltimore Orioles' Pete Alonso during the fifth inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Seattle Mariners pitcher George Kirby walks back onto the mound after surrendering a home run to Baltimore Orioles' Pete Alonso during the fifth inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Seattle Mariners' Julio Rodríguez walks off the field after striking out against Baltimore Orioles pitcher Brandon Young during the third inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Seattle Mariners' Julio Rodríguez walks off the field after striking out against Baltimore Orioles pitcher Brandon Young during the third inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Baltimore Orioles pitcher Brandon Young throws during the first inning of a baseball game against the Seattle Mariners, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Baltimore Orioles pitcher Brandon Young throws during the first inning of a baseball game against the Seattle Mariners, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Baltimore Orioles' Pete Alonso watches his home run hit off Seattle Mariners pitcher George Kirby during the sixth inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Baltimore Orioles' Pete Alonso watches his home run hit off Seattle Mariners pitcher George Kirby during the sixth inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Baltimore Orioles' Jackson Holliday, center, celebrates his grand slam home run with Pete Alonso (25) hit off Seattle Mariners pitcher Domingo Gonzalez which scored Taylor Ward, Pete Alonso and Leody Taveras during the seventh inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Baltimore Orioles' Jackson Holliday, center, celebrates his grand slam home run with Pete Alonso (25) hit off Seattle Mariners pitcher Domingo Gonzalez which scored Taylor Ward, Pete Alonso and Leody Taveras during the seventh inning of a baseball game, Wednesday, June 10, 2026, in Baltimore. (AP Photo/Terrance Williams)

Recommended Articles